Jason Hsu - 08 Sep 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jason Hsu
Issuer symbol
IMMX
Transactions as of
08 Sep 2023
Net transactions value
+$25,317
Form type
4
Filing time
12 Sep 2023, 16:58:37 UTC
Previous filing
14 Aug 2023
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Purchase $25,317 +10,000 +1.5% $2.53 685,000 08 Sep 2023 Direct F1
holding IMMX Common Stock 3,915,913 08 Sep 2023 See Footnote F2
holding IMMX Common Stock 50,000 08 Sep 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This figure is the weighted average sales price of multiple trades ranging from $2.51 to $2.559 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.
F2 Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
F3 Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.